Loading data
DOCSNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 644.86 m USD | 570.4 m USD | 475.42 m USD | 419.05 m USD | 343.55 m USD |
| Cost of revenue | 70.33 m USD | 55.87 m USD | 50.67 m USD | 53.49 m USD | 39.79 m USD |
| Gross profit | 574.54 m USD | 514.53 m USD | 424.75 m USD | 365.56 m USD | 303.76 m USD |
| Research and development expense | 130.7 m USD | 93.04 m USD | 81.98 m USD | 80.19 m USD | 62.35 m USD |
| Operating profit | 214.92 m USD | 227.8 m USD | 163.88 m USD | 125.11 m USD | 113.54 m USD |
| Profit before tax | 250.01 m USD | 263.57 m USD | 185.2 m USD | 133.16 m USD | 114.01 m USD |
| Income tax expense | 53.95 m USD | 40.39 m USD | 37.62 m USD | 20.34 m USD | -40.78 m USD |
| Net income (reported basis) | 196.1 m USD | 223.2 m USD | 147.6 m USD | 112.8 m USD | 154.8 m USD |
| Net income attributable to common shareholders | — | — | 147.58 m USD | 112.82 m USD | 133.26 m USD |
| Basic earnings per share | 1.05 USD/share | 1.19 USD/share | 0.78 USD/share | 0.58 USD/share | 0.82 USD/share |
| Diluted earnings per share | 0.98 USD/share | 1.11 USD/share | 0.72 USD/share | 0.53 USD/share | 0.7 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.